MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ecco-jcc/jjaf179

Медицинская библиотека · Journal of Crohn's & colitis · 2025

Disease duration impacts intestinal gene expression profiles in Crohn's disease but not in ulcerative colitis.

Ibing Susanne, Tastad Christopher, Renard Bernhard Y, Cohen Louis J, Argmann Carmen, Helmus Drew, Schadt Eric E, Merad Miriam, Kukreja Anjli, Visvanathan Sudha, Sands Bruce E, Dubinsky Marla, Suarez-Fariñas Mayte, Colombel Jean-Frédéric, Böttinger Erwin P, Cho Judy H, Petralia Francesca, Ungaro Ryan C

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Disease duration is associated with lower treatment response and accrual of bowel damage in Crohn's disease (CD), but not in ulcerative colitis (UC). We aimed to understand intestinal transcriptomic changes associated with disease duration in CD and UC.

METHODS

We analyzed intestinal tissue RNA sequencing data from two independent prospective cohorts of CD and UC patients, the Mount Sinai Crohn's and Colitis Registry (MSCCR; nCD = 498, nUC = 421), and the Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD; nCD = 777, nUC = 440). We conducted differential expression analysis and subsequent pathway analyses of significantly up- or down-regulated genes, and examined cell type-specific expression of significant genes and pathways in ileal single-cell RNA sequencing data from CD patients (n = 18). We then assessed the association of significant pathways with treatment response in an infliximab-treated CD cohort.

RESULTS

Significantly more genes were differentially expressed with increasing disease duration in CD compared to UC in both cohorts (MSCCR: nCD = 1472, nUC = 227; SPARC: nCD = 1248, nUC = 25; q-value < 0.05). A shared gene signature with 263 down- and 135 up-regulated genes in longer standing disease was identified. Pathway analyses revealed significant enrichment in pathways related to oxidative phosphorylation, mitochondrial dysfunction, cholesterol biosynthesis, liver X receptor/retinoid X receptor (LXR/RXR) activation, and protein modifications. Pre-treatment intestinal gene expression of four disease duration-related pathways were associated with non-response to infliximab.

CONCLUSION

Disease duration influences intestinal gene expression in CD but significantly less so in UC. The identified pathways and genes may inform development of differing biomarkers and treatment strategies in shorter versus longer standing CD.

Для цитирования: Ibing Susanne, Tastad Christopher, Renard Bernhard Y, Cohen Louis J, Argmann Carmen, Helmus Drew, Schadt Eric E, Merad Miriam, Kukreja Anjli, Visvanathan Sudha, Sands Bruce E, Dubinsky Marla, Suarez-Fariñas Mayte, Colombel Jean-Frédéric, Böttinger Erwin P, Cho Judy H, Petralia Francesca, Ungaro Ryan C. Disease duration impacts intestinal gene expression profiles in Crohn's disease but not in ulcerative colitis.. Journal of Crohn's & colitis. 2025. DOI: 10.1093/ecco-jcc/jjaf179.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.